173 related articles for article (PubMed ID: 22896025)
1. Survival, causes of death, and prognostic factors in systemic sclerosis: analysis of 947 Brazilian patients.
Sampaio-Barros PD; Bortoluzzo AB; Marangoni RG; Rocha LF; Del Rio AP; Samara AM; Yoshinari NH; Marques-Neto JF
J Rheumatol; 2012 Oct; 39(10):1971-8. PubMed ID: 22896025
[TBL] [Abstract][Full Text] [Related]
2. Survival, causes of death, and risk factors associated with mortality in Spanish systemic sclerosis patients: results from a single university hospital.
Joven BE; Almodovar R; Carmona L; Carreira PE
Semin Arthritis Rheum; 2010 Feb; 39(4):285-93. PubMed ID: 19782387
[TBL] [Abstract][Full Text] [Related]
3. Influence of clinical features, serum antinuclear antibodies, and lung function on survival of patients with systemic sclerosis.
Jacobsen S; Ullman S; Shen GQ; Wiik A; Halberg P
J Rheumatol; 2001 Nov; 28(11):2454-9. PubMed ID: 11708418
[TBL] [Abstract][Full Text] [Related]
4. Determinants of morbidity and mortality of systemic sclerosis in Canada.
Al-Dhaher FF; Pope JE; Ouimet JM
Semin Arthritis Rheum; 2010 Feb; 39(4):269-77. PubMed ID: 18706680
[TBL] [Abstract][Full Text] [Related]
5. Predictors of survival and causes of death in Japanese patients with systemic sclerosis.
Hashimoto A; Tejima S; Tono T; Suzuki M; Tanaka S; Matsui T; Tohma S; Endo H; Hirohata S
J Rheumatol; 2011 Sep; 38(9):1931-9. PubMed ID: 21765111
[TBL] [Abstract][Full Text] [Related]
6. Causes and risk factors for death in systemic sclerosis: a study from the EULAR Scleroderma Trials and Research (EUSTAR) database.
Tyndall AJ; Bannert B; Vonk M; Airò P; Cozzi F; Carreira PE; Bancel DF; Allanore Y; Müller-Ladner U; Distler O; Iannone F; Pellerito R; Pileckyte M; Miniati I; Ananieva L; Gurman AB; Damjanov N; Mueller A; Valentini G; Riemekasten G; Tikly M; Hummers L; Henriques MJ; Caramaschi P; Scheja A; Rozman B; Ton E; Kumánovics G; Coleiro B; Feierl E; Szucs G; Von Mühlen CA; Riccieri V; Novak S; Chizzolini C; Kotulska A; Denton C; Coelho PC; Kötter I; Simsek I; de la Pena Lefebvre PG; Hachulla E; Seibold JR; Rednic S; Stork J; Morovic-Vergles J; Walker UA
Ann Rheum Dis; 2010 Oct; 69(10):1809-15. PubMed ID: 20551155
[TBL] [Abstract][Full Text] [Related]
7. Association of C-reactive protein with high disease activity in systemic sclerosis: results from the Canadian Scleroderma Research Group.
Muangchan C; Harding S; Khimdas S; Bonner A; ; Baron M; Pope J
Arthritis Care Res (Hoboken); 2012 Sep; 64(9):1405-14. PubMed ID: 22556030
[TBL] [Abstract][Full Text] [Related]
8. Prognostic factors of mortality and 2-year survival analysis of systemic sclerosis with pulmonary arterial hypertension in Thailand.
Foocharoen C; Nanagara R; Kiatchoosakun S; Suwannaroj S; Mahakkanukrauh A
Int J Rheum Dis; 2011 Aug; 14(3):282-9. PubMed ID: 21816025
[TBL] [Abstract][Full Text] [Related]
9. Survival and causes of death in an unselected and complete cohort of Norwegian patients with systemic sclerosis.
Hoffmann-Vold AM; Molberg Ø; Midtvedt Ø; Garen T; Gran JT
J Rheumatol; 2013 Jul; 40(7):1127-33. PubMed ID: 23637316
[TBL] [Abstract][Full Text] [Related]
10. Causes of death and poor survival prognostic factors in thai patients with systemic sclerosis.
Ruangjutipopan S; Kasitanon N; Louthrenoo W; Sukitawut W; Wichainun R
J Med Assoc Thai; 2002 Nov; 85(11):1204-9. PubMed ID: 12546318
[TBL] [Abstract][Full Text] [Related]
11. Renal function is mostly preserved in patients with systemic sclerosis.
Scheja A; Bartosik I; Wuttge DM; Hesselstrand R
Scand J Rheumatol; 2009; 38(4):295-8. PubMed ID: 19214870
[TBL] [Abstract][Full Text] [Related]
12. Myopathy is a poor prognostic feature in systemic sclerosis: results from the Canadian Scleroderma Research Group (CSRG) cohort.
Jung M; Bonner A; Hudson M; Baron M; Pope JE;
Scand J Rheumatol; 2014; 43(3):217-20. PubMed ID: 24650305
[TBL] [Abstract][Full Text] [Related]
13. Changes in causes of death in systemic sclerosis, 1972-2002.
Steen VD; Medsger TA
Ann Rheum Dis; 2007 Jul; 66(7):940-4. PubMed ID: 17329309
[TBL] [Abstract][Full Text] [Related]
14. Investigation of prognostic factors for skin sclerosis and lung function in Japanese patients with early systemic sclerosis: a multicentre prospective observational study.
Hasegawa M; Asano Y; Endo H; Fujimoto M; Goto D; Ihn H; Inoue K; Ishikawa O; Kawaguchi Y; Kuwana M; Muro Y; Ogawa F; Sasaki T; Takahashi H; Tanaka S; Takehara K; Sato S
Rheumatology (Oxford); 2012 Jan; 51(1):129-33. PubMed ID: 22072085
[TBL] [Abstract][Full Text] [Related]
15. Is vasculopathy associated with systemic sclerosis more severe in men?
Panopoulos ST; Bournia VK; Sfikakis PP
J Rheumatol; 2013 Jan; 40(1):46-51. PubMed ID: 23118107
[TBL] [Abstract][Full Text] [Related]
16. Clinical prediction of 5-year survival in systemic sclerosis: validation of a simple prognostic model in EUSTAR centres.
Fransen J; Popa-Diaconu D; Hesselstrand R; Carreira P; Valentini G; Beretta L; Airo P; Inanc M; Ullman S; Balbir-Gurman A; Sierakowski S; Allanore Y; Czirjak L; Riccieri V; Giacomelli R; Gabrielli A; Riemekasten G; Matucci-Cerinic M; Farge D; Hunzelmann N; Van den Hoogen FH; Vonk MC
Ann Rheum Dis; 2011 Oct; 70(10):1788-92. PubMed ID: 21784727
[TBL] [Abstract][Full Text] [Related]
17. Clinical subsets, skin thickness progression rate, and serum antibody levels in systemic sclerosis patients with anti-topoisomerase I antibody.
Perera A; Fertig N; Lucas M; Rodriguez-Reyna TS; Hu P; Steen VD; Medsger TA
Arthritis Rheum; 2007 Aug; 56(8):2740-6. PubMed ID: 17665460
[TBL] [Abstract][Full Text] [Related]
18. Survival and causes of death in 366 Hungarian patients with systemic sclerosis.
Czirják L; Kumánovics G; Varjú C; Nagy Z; Pákozdi A; Szekanecz Z; Szucs G
Ann Rheum Dis; 2008 Jan; 67(1):59-63. PubMed ID: 17519276
[TBL] [Abstract][Full Text] [Related]
19. [Causes of death of patients with systemic sclerosis].
Chwieśko S; Sierakowski S; Kowal-Bielecka O
Pol Merkur Lekarski; 2006 Oct; 21(124):341-4. PubMed ID: 17205772
[TBL] [Abstract][Full Text] [Related]
20. Predictors and outcomes of scleroderma renal crisis: the high-dose versus low-dose D-penicillamine in early diffuse systemic sclerosis trial.
DeMarco PJ; Weisman MH; Seibold JR; Furst DE; Wong WK; Hurwitz EL; Mayes M; White B; Wigley F; Barr W; Moreland L; Medsger TA; Steen V; Martin RW; Collier D; Weinstein A; Lally E; Varga J; Weiner SR; Andrews B; Abeles M; Clements PJ
Arthritis Rheum; 2002 Nov; 46(11):2983-9. PubMed ID: 12428241
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
